Global Endoparasiticide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Endoparasiticide Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Endoparasiticide report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Endoparasiticide market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Veterinary Hospitals or Clinics and Animal Farms are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Endoparasiticide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Endoparasiticide key manufacturers include Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc. Boehringer Ingelheim, Elanco, Zoetis are top 3 players and held % sales share in total in 2022.
Endoparasiticide can be divided into Ear Tags, Tablets, Injectables and Feed Additives, etc. Ear Tags is the mainstream product in the market, accounting for % sales share globally in 2022.
Endoparasiticide is widely used in various fields, such as Veterinary Hospitals or Clinics, Animal Farms and Home Care Settings,, etc. Veterinary Hospitals or Clinics provides greatest supports to the Endoparasiticide industry development. In 2022, global % sales of Endoparasiticide went into Veterinary Hospitals or Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endoparasiticide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Segment by Type
Ear Tags
Tablets
Injectables
Feed Additives
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endoparasiticide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Endoparasiticide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Endoparasiticide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Endoparasiticide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Endoparasiticide introduction, etc. Endoparasiticide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Endoparasiticide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Endoparasiticide industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Endoparasiticide key manufacturers include Boehringer Ingelheim, Elanco, Zoetis, Merck, Virbac, Novartis AG, Ceva Sante Animlae, Bayer AG and Eli Lilly, etc. Boehringer Ingelheim, Elanco, Zoetis are top 3 players and held % sales share in total in 2022.
Endoparasiticide can be divided into Ear Tags, Tablets, Injectables and Feed Additives, etc. Ear Tags is the mainstream product in the market, accounting for % sales share globally in 2022.
Endoparasiticide is widely used in various fields, such as Veterinary Hospitals or Clinics, Animal Farms and Home Care Settings,, etc. Veterinary Hospitals or Clinics provides greatest supports to the Endoparasiticide industry development. In 2022, global % sales of Endoparasiticide went into Veterinary Hospitals or Clinics filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Endoparasiticide market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Boehringer Ingelheim
Elanco
Zoetis
Merck
Virbac
Novartis AG
Ceva Sante Animlae
Bayer AG
Eli Lilly
Vetoquinol
Segment by Type
Ear Tags
Tablets
Injectables
Feed Additives
Segment by Application
Veterinary Hospitals or Clinics
Animal Farms
Home Care Settings
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Endoparasiticide market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Endoparasiticide, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Endoparasiticide industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Endoparasiticide in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Endoparasiticide introduction, etc. Endoparasiticide Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Endoparasiticide market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.